sorafenib has been researched along with jaw in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (jaw) | Trials (jaw) | Recent Studies (post-2010) (jaw) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 7,554 | 157 | 1,917 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucci, L; Camelli, V; Garuti, F; Spinardi, L; Trevisani, F | 1 |
2 other study(ies) available for sorafenib and jaw
| Article | Year |
|---|---|
Sorafenib: osteonecrosis of the jaw.
Topics: Antineoplastic Agents; Humans; Jaw; Niacinamide; Osteonecrosis; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib | 2015 |
Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Disease Progression; Fatal Outcome; Humans; Jaw; Liver Neoplasms; Male; Niacinamide; Osteonecrosis; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Tomography, X-Ray Computed | 2016 |